サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1420161

中南米の放射性トレーサー市場の2030年予測-地域分析：トレーサータイプ別、検査タイプ別、用途別、エンドユーザー別

South & Central America Radioactive Tracer Market Forecast to 2030 - Regional Analysis - by Tracer Type, Test Type, Application, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 113 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.53円
中南米の放射性トレーサー市場の2030年予測-地域分析：トレーサータイプ別、検査タイプ別、用途別、エンドユーザー別
出版日: 2023年12月04日
発行: The Insight Partners
ページ情報: 英文 113 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中南米の放射性トレーサー市場は2022年に4億7,696万米ドルと評価され、2030年には16億3,433万米ドルに達すると予測され、2022年から2030年までのCAGRは16.6%で成長すると予測されています。

がん診断における放射性トレーサーの利用が中南米放射性トレーサー市場を煽る

がん患者は世界的に増加しており、ヘルスケア分野における腫瘍学は著しく発展している分野です。Institute for Health Metrics and Evaluation（IHME）によると、がんは心血管障害に次ぐ2番目の主要死因です。がんの診断と治療における先端材料と薬剤の使用は、腫瘍学の顕著な発展とともに急増しています。放射性トレーサーを用いた画像診断は、前立腺がん、婦人科がん、血液を介するがんなど、がんの種類を正確に診断するために用いられる高度な診断法のひとつです。体内に注入された放射性トレーサーは、がん特有の部位に付着し、がんの種類を正確に診断します。トレーサーはまた、がんの発生段階を判断するのに役立ち、ほとんどの場合、効果的な治療とより早い回復を可能にします。PETとSPECTは、腫瘍の検出にガンマ線放出核種を使用する核画像診断法の一つです。腫瘍が成長するにつれて、PETやSPECTの結合体への取り込みが時間とともに増加し、核画像薬剤の存在によりコントラストが向上します。これにより血液クリアランスが促進され、鮮明な診断画像が得られるようになります。がんの検出に最もよく使われる放射性トレーサーはF-18フルオロデオキシグルコース（18F-FDG）で、ブドウ糖や砂糖に似た化合物です。がん細胞は非常に活発で、正常細胞よりも多くのエネルギー、すなわち余分なブドウ糖を必要とします。PETやSPECTなどの画像診断装置は、FDGが放出するこのエネルギーを検出し、体内の放射性トレーサーの位置を示す画像を作成します。これにより、患者の体内のがん細胞の位置を特定し、がんの種類や病期に応じて治療を調整することができます。このように、がん診断における放射性トレーサーの使用の増加は、推定期間中の市場拡大を促進すると予想されます。

中南米の放射性トレーサー市場概要

中南米の放射性トレーサー市場は、ブラジル、アルゼンチン、その他中南米に区分されます。同地域の市場は、がん患者の増加、政府のイニシアチブの高まり、放射性トレーサーの研究開発の高まりにより成長が見込まれています。

中南米の放射性トレーサー市場の収益と2030年までの予測（金額）

中南米の放射性トレーサー市場セグメンテーション

中南米の放射性トレーサー市場は、トレーサータイプ、検査タイプ、エンドユーザー、用途、国によって区分されます。トレーサータイプ別では、中南米の放射性トレーサー市場はテクネチウム-99m&Tc-97m、ヨウ素131、鉄-59、ルテチウム-171、塩化ルビジウム（Rb-82）&アンモニア（N-13）、スカンジウム-46、シーボロギウム-269、ハッシウム-269に区分される、クエン酸ガリウムGa 67、前立腺特異的膜抗原（PSMA）（Ga-68）、FDDNP（F-18）＆FDOPA（F-18）、リン-32＆クロム-51、タリウム-201、F-18 FDG、F-18 FAPI、Ga-68 FAPI、F-18 PSMA、DOTATOC/DOTANOC/DOTATATE（Ga-68）、その他。2022年には、その他セグメントが最大の市場シェアを占めました。

検査タイプ別に見ると、中南米の放射性トレーサー市場はPET、SPECT、その他に区分されます。PET分野が2022年に最大の市場シェアを占めました。

エンドユーザー別では、中南米の放射性トレーサー市場は病院＆クリニック、診断センター、学術＆研究機関、その他に区分されます。病院＆クリニックセグメントが2022年に最大の市場シェアを占めました。

用途別では、中南米の放射性トレーサー市場は、腫瘍学、肺、神経学、心臓学、その他に区分されます。2022年には腫瘍分野が最大の市場シェアを占めました。

国別に見ると、中南米の放射性トレーサー市場はブラジル、アルゼンチン、その他中南米に区分されます。その他中南米が2022年の中南米放射性トレーサー市場シェアを独占しました。

Rotem Industries Ltd、Invicro LLC、Cardinal Health Inc、Newcastle University、Novartis AG、Curium、IBA Radiopharma Solutionsは、中南米の放射性トレーサー市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 中南米の放射性トレーサー市場：主要産業力学

  • 主な市場促進要因
    • 慢性疾患の有病率の上昇
    • 核イメージング技術の利用の増加
  • 市場抑制要因
    • 放射性トレーサーの短い使用期限
    • 核医学画像診断手順の代替品の入手可能性
  • 市場機会
    • 新興経済国の存在と人口の増加
    • 標的治療のための個別化放射性医薬品の開発
  • 今後の動向
    • がん診断における放射性トレーサーの使用
  • インパクト分析

第5章 放射性トレーサー市場：中南米市場分析

  • 放射性トレーサー市場の収益、2022年～2030年

第6章 中南米の放射性トレーサー市場-収益と2030年までの予測：トレーサータイプ別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）トレーサータイプ別
  • テクネチウム99mおよびTC-97m
  • ヨウ素131
  • 鉄59
  • ルテチウム171
  • RB82およびアンモニアN-13
  • スカンジウム46
  • シーボーギウム-269
  • ハッシウム-269
  • クエン酸ガリウムGA67
  • PSMA GA68
  • FDDNP（F-18）およびFDOPA（f-18）
  • リン32およびクロム-51
  • タリウム-201
  • F-18 FDG
  • F-18 FAPI
  • GA 68 FAPI
  • F-18 PSMA
  • DOTATOC/DOTANOC/DOTATATE GA 68
  • その他

第7章 中南米の放射性トレーサー市場-収益と2030年までの予測：検査タイプ別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）検査タイプ別
  • PET
  • SPECT
  • その他

第8章 中南米の放射性トレーサー市場-収益と2030年までの予測：用途別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）用途別
  • 腫瘍
  • 肺
  • 神経学
  • 循環器
  • その他

第9章 中南米の放射性トレーサー市場-収益と2030年までの予測：エンドユーザー別

  • 放射性トレーサー市場：2022年・2030年収益シェア（%）エンドユーザー別
  • 病院および診療所
  • 診断センター
  • 学術・研究機関
  • その他

第10章 中南米の放射性トレーサー市場：国別分析

  • ブラジル
  • アルゼンチン
  • その他中南米

第11章 放射性トレーサー市場の業界情勢

  • 有機的開発
  • 無機的開発

第12章 放射性トレーサー市場：主要企業プロファイル

  • Rotem Industries Ltd
  • Invicro LLC
  • Cardinal Health Inc
  • Newcastle University
  • Novartis AG
  • Curium
  • General Electric Co
  • IBA Radiopharma Solutions

第13章 付録

図表

List Of Tables

  • Table 1. South & Central America Radioactive Tracer Market Segmentation
  • Table 2. Principal Radionuclides Used in Radioactive Tracer
  • Table 3. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 4. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 5. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 6. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 7. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 8. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 9. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 10. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Tracer Types
  • Table 12. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Test Type
  • Table 13. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - Application
  • Table 14. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 15. Organic Developments Done by Companies
  • Table 16. Inorganic Developments Done by Companies
  • Table 17. Glossary of Terms, South & Central America Radioactive Tracer Market

List Of Figures

  • Figure 1. South & Central America Radioactive Tracer Market Segmentation, By Country
  • Figure 2. South & Central America Radioactive Tracer Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. South & Central America Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030
  • Figure 5. South & Central America Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • Figure 6. Technetium 99m and TC-97m: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Iodine 131: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Iron 59: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Lutetium- 171: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. RB82 and ammonia N-13: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Scandium 46: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Seaborgium-269: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Hassium -269: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Gallium Citrate GA 67: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. PSMA GA68: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. FDDNP (F-18) and FDOPA (f-18): South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Phosphorus 32 and Chromium -51: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Thallium-201: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. F-18 FDG: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. F-18 FAPI: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. GA 68 FAPI: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. F-18 PSMA: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DOTATOC/DOTANOC/DOTATATE Ga 68: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. South & Central America Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • Figure 26. PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. SPECT: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. South & Central America Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 30. Oncology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pulmonary: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Neurology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Cardiology: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. South & Central America Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 36. Hospitals and Clinics: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Diagnostic Centers: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 38. Academic and Research Institutes: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 39. Others: South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 40. South & Central America Radioactive Tracer Market, By Geography, 2022 ($Mn)
  • Figure 41. South & Central America Radioactive Tracer Market, By Key Countries, 2022 and 2030 (%)
  • Figure 42. Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 43. Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
目次
Product Code: BMIRE00029123

The South & Central America radioactive tracer market was valued at US$ 476.96 million in 2022 and is expected to reach US$ 1,634.33 million by 2030; it is estimated to grow at a CAGR of 16.6% from 2022 to 2030.

Use of Radioactive Tracer in Cancer Diagnosis fuel the South & Central America Radioactive Tracer Market

Oncology is a significantly developing field in the healthcare sector, as cancer cases are increasing worldwide. According to Institute for Health Metrics and Evaluation (IHME), cancer is the second major cause of death after cardiovascular disorders. The use of advanced materials and drugs in the diagnosis and treatment of cancer has surged with prominent developments in oncology. Radioactive tracer-based imaging is one of the advanced diagnostic methods used to accurately diagnose cancer types, such as prostate cancer, gynecological cancer, and blood-borne cancer. Once injected into the body, these radioactive tracers attach to the cancer-specific sites, accurately diagnosing the cancer type. Tracer also helps determine the cancer development stage, enabling effective treatment and faster recovery in most cases. PET and SPECT are among the nuclear imaging techniques that use gamma emitters for detecting tumors. As the tumor grows, its uptake of the PET and SPECT conjugate increases over time, which improves contrast due to the presence of nuclear imaging agents. This further leads to blood clearance due to which clear diagnostic images can be generated. The most commonly used radioactive tracer for detecting cancer is F-18 fluorodeoxyglucose (18F-FDG), a compound similar to glucose or sugar. Cancer cells are highly active and need more energy, i.e., extra glucose, than normal cells. Imaging devices such as PET or SPECT detect this energy released by FDG to create an image showing the location of a radioactive tracer in the body. This helps determine the location of cancerous cells in the patient's body so that the treatment can be tailored according to the type and stage of cancer. Thus, the increasing use of radioactive tracer in cancer diagnostics is anticipated to drive market expansion during the estimated timeframe.

South & Central America Radioactive Tracer Market Overview

The South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the increasing number of cancer cases, growing government initiatives, and rising research and development for radioactive tracer.

South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Radioactive Tracer Market Segmentation

The South & Central America radioactive tracer market is segmented based on tracer type, test type, end user, application, and country. Based on tracer type, the South & Central America radioactive tracer market is segmented into technetium-99m & Tc-97m, iodine-131, iron-59, lutetium-171, rubidium (Rb-82) chloride & ammonia (N-13), scandium-46, seaborgium-269, hassium-269, Gallium citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), phosphorus-32 & chromium-51, thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and others. The others segment held the largest market share in 2022.

Based on test type, the South & Central America radioactive tracer market is segmented into PET, SPECT, and others. The PET segment held the largest market share in 2022.

Based on end user, the South & Central America radioactive tracer market is segmented into hospitals & clinics, diagnostic centers, academic & research institutes, and others. The hospitals & clinics segment held the largest market share in 2022.

Based on application, the South & Central America radioactive tracer market is segmented into oncology, pulmonary, neurology, cardiology, and others. The oncology segment held the largest market share in 2022.

Based on country, the South & Central America radioactive tracer market is segmented into Brazil, Argentina, and the Rest of South & Central America. The Rest of South & Central America dominated the South & Central America radioactive tracer market share in 2022.

Rotem Industries Ltd, Invicro LLC, Cardinal Health Inc, Newcastle University, Novartis AG, Curium, and IBA Radiopharma Solutions are some of the leading players operating in the South & Central America radioactive tracer market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America radioactive tracer market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the South & Central America radioactive tracer market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the South & Central America radioactive tracer market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Radioactive Tracer Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Rising Prevalence of Chronic Diseases
    • 4.1.2 Increasing Use of Nuclear Imaging Techniques
  • 4.2 Market Restraints
    • 4.2.1 Short Shelf-Life of Radioactive Tracer
    • 4.2.2 Availability of Substitutes to Nuclear Diagnostic Imaging Procedures
  • 4.3 Market Opportunities
    • 4.3.1 Presence of Emerging Economies and Growing Population
    • 4.3.2 Development of Personalized Radiopharmaceuticals for Targeted Therapies
  • 4.4 Future Trends
    • 4.4.1 Use of Radioactive Tracer in Cancer Diagnosis
  • 4.5 Impact Analysis:

5. Radioactive Tracer Market - South & Central America Market Analysis

  • 5.1 Radioactive Tracer Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Tracer Types

  • 6.1 Overview
  • 6.2 Radioactive Tracer Market Revenue Share, by Tracer Types 2022 & 2030 (%)
  • 6.3 Technetium 99m and TC-97m
    • 6.3.1 Overview
    • 6.3.2 Technetium 99m and TC-97m: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Iodine 131
    • 6.4.1 Overview
    • 6.4.2 Iodine 131: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Iron 59
    • 6.5.1 Overview
    • 6.5.2 Iron 59: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Lutetium- 171
    • 6.6.1 Overview
    • 6.6.2 Lutetium- 171: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.7 RB82 and ammonia N-13
    • 6.7.1 Overview
    • 6.7.2 RB82 and ammonia N-13: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.8 Scandium 46
    • 6.8.1 Overview
    • 6.8.2 Scandium 46: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.9 Seaborgium-269
    • 6.9.1 Overview
    • 6.9.2 Seaborgium-269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.10 Hassium -269
    • 6.10.1 Overview
    • 6.10.2 Hassium -269: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.11 Gallium Citrate GA 67
    • 6.11.1 Overview
    • 6.11.2 Gallium Citrate GA 67: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.12 PSMA GA68
    • 6.12.1 Overview
    • 6.12.2 PSMA GA68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.13 FDDNP (F-18) and FDOPA (f-18)
    • 6.13.1 Overview
    • 6.13.2 FDDNP (F-18) and FDOPA (f-18): Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.14 Phosphorus 32 and Chromium -51
    • 6.14.1 Overview
    • 6.14.2 Phosphorus 32 and Chromium -51: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.15 Thallium-201
    • 6.15.1 Overview
    • 6.15.2 Thallium-201: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.16 F-18 FDG
    • 6.16.1 Overview
    • 6.16.2 F-18 FDG: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.17 F-18 FAPI
    • 6.17.1 Overview
    • 6.17.2 F-18 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.18 GA 68 FAPI
    • 6.18.1 Overview
    • 6.18.2 GA 68 FAPI: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.19 F-18 PSMA
    • 6.19.1 Overview
    • 6.19.2 F-18 PSMA: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.20 DOTATOC/DOTANOC/DOTATATE Ga 68
    • 6.20.1 Overview
    • 6.20.2 DOTATOC/DOTANOC/DOTATATE Ga 68: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.21 Others
    • 6.21.1 Overview
    • 6.21.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Test Type

  • 7.1 Overview
  • 7.2 Radioactive Tracer Market Revenue Share, by Test Type 2022 & 2030 (%)
  • 7.3 PET
    • 7.3.1 Overview
    • 7.3.2 PET: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 SPECT
    • 7.4.1 Overview
    • 7.4.2 SPECT: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by Application.

  • 8.1 Overview
  • 8.2 Radioactive Tracer Market Revenue Share, by Application 2022 & 2030 (%)
  • 8.3 Oncology
    • 8.3.1 Overview
    • 8.3.2 Oncology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pulmonary
    • 8.4.1 Overview
    • 8.4.2 Pulmonary: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Neurology
    • 8.5.1 Overview
    • 8.5.2 Neurology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Cardiology
    • 8.6.1 Overview
    • 8.6.2 Cardiology: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Radioactive Tracer Market - Revenue and Forecast to 2030 - by End User

  • 9.1 Overview
  • 9.2 Radioactive Tracer Market Revenue Share, by End User 2022 & 2030 (%)
  • 9.3 Hospitals and Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals and Clinics: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Diagnostic Centers
    • 9.4.1 Overview
    • 9.4.2 Diagnostic Centers: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Academic and Research Institutes
    • 9.5.1 Overview
    • 9.5.2 Academic and Research Institutes: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Radioactive Tracer Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Radioactive Tracer Market - Country Analysis

  • 10.1 South & Central America Radioactive Tracer Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 South & Central America Radioactive Tracer Market by Country
      • 10.1.2.1 Brazil
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 Brazil Radioactive Tracer Market, by Tracer Types
        • 10.1.2.1.4 Brazil Radioactive Tracer Market, by Test Type
        • 10.1.2.1.5 Brazil Radioactive Tracer Market, by Application
        • 10.1.2.1.6 Brazil Radioactive Tracer Market, by End-User
      • 10.1.2.2 Argentina
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Argentina Radioactive Tracer Market, by Tracer Types
        • 10.1.2.2.4 Argentina Radioactive Tracer Market, by Test Type
        • 10.1.2.2.5 Argentina Radioactive Tracer Market, by Application
        • 10.1.2.2.6 Argentina Radioactive Tracer Market, by End-User
      • 10.1.2.3 Rest of South & Central America
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America Radioactive Tracer Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Rest of South & Central America Radioactive Tracer Market, by Tracer Types
        • 10.1.2.3.4 Rest of South & Central America Radioactive Tracer Market, by Test Type
        • 10.1.2.3.5 Rest of South & Central America Radioactive Tracer Market, by Application
        • 10.1.2.3.6 Rest of South & Central America Radioactive Tracer Market, by End-User

11. Radioactive Tracer Market Industry Landscape

  • 11.1 Overview
  • 11.2 Organic Developments
    • 11.2.1 Overview
  • 11.3 Inorganic Developments
    • 11.3.1 Overview

12. Radioactive Tracer Market, Key Company Profiles

  • 12.1 Rotem Industries Ltd
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Invicro LLC
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Cardinal Health Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Newcastle University
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Novartis AG
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Curium
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 General Electric Co
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 IBA Radiopharma Solutions
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms